Mammography Quality Standards Act and Program
October 2012 marks the 20th anniversary of the Mammography Quality Standards Act (MQSA). This legislation established national standards for accreditation, certification, and inspection of mammography facilities in the U.S. Because of these standards, millions of women who receive mammograms in the U.S. each year can be confident they are receiving high-quality, consistent and reliable breast imaging at mammography facilities across the country.
Through this legislation, FDA staff helped create an environment where nearly all mammography facilities operate according to national standards, free from major inspection violations. These standards have also helped optimize radiation doses, and ultimately contribute to improved detection, earlier treatment, and better outcomes for breast cancer patients.
FDA’s implementation of MQSA has encouraged health care providers and equipment manufacturers to improve quality and seek excellence while giving women the information they need to make better-informed health care decisions.
In 2012, twenty years after Congress passed MQSA, FDA's goal for the MQSA program remains, to improve the quality of the nation's mammography services. The Division of Mammography Quality Standards within CDRH continues to work toward that goal, keeping in mind an aim of affording quality mammography services for all of our nation's women with an efficient and least burdensome approach to facilities.
FDA Extends the Approval of the State of Texas and the American College of Radiology Accreditation Bodies to April 28, 2014 (5/1/13)
MQSA National Statistics
FDA Approves the State of Iowa to Serve as Accreditation Body for the 2013-2020 Term (4/3/13)
- MQSA Alternative Standard #23: Correction Period When Components of the Fuji Aspire HD, Aspire HD Plus and Aspire HD-s Full Field Digital Mammography imaging systems Full Field Digital Mammography imaging systems Fail Quality Control Tests
FDA Lowers Interest Rate on Overdue Payments of Inspection Fees from 10.5% to 10.375% APR (1/24/13)
2011 Report to Congress on the Performance of Accreditation Bodies (1/16/13)
FDA Approves the State of Arkansas to Serve as Accreditation Body for the 2013-2020 Term (1/10/13)